טוען...
Docking Prediction of Amantadine in the Receptor Binding Domain of Spike Protein of SARS-CoV-2
[Image: see text] Amantadine has recently been shown to improve patients with COVID-19. In addition to its known mechanism of actions, we performed docking prediction of this drug on the receptor-binding domain of severe acute respiratory syndrome coronavirus 2, SARS-CoV-2. We hypothesize that such...
שמור ב:
| הוצא לאור ב: | ACS Pharmacol Transl Sci |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American
Chemical Society
2020
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7737314/ https://ncbi.nlm.nih.gov/pubmed/33344913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.0c00172 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|